Navigation Links
Entomological Society of America announces 2013 fellows
Date:7/31/2013

tic entomological methods, including a five-year Planetary Biodiversity Inventories award for the study of Miridae, under which he developed one of the first web-based collection data-capture software applications known as Arthropod Easy Capture. He received a four-year award for Advancing Digitization of Biological Collections, which funded a consortium of 32 entomological and botanical institutions dedicated to the capture of specimen data documenting herbivore and parasitoid relationships with the North American flora.

Randall Schuh is married to Brenda Massie. They have a daughter named Ella. He is a skilled woodworker, and in recent years he has fulfilled the lifelong ambition to harvest, mill, and dry his own lumber. He has published in the field of woodworking as well as entomology.

DR. REN FEYEREISEN, director of research at the Institut National de la Recherche Agronomique in France, is recognized internationally for his research on insect biochemistry, physiology, and toxicology, and especially the functions of cytochrome P450 enzymes. Feyereisen received his Ph.D. from Louis Pasteur University in Strasbourg, France in 1979. After postdoctoral fellowships at the Agricultural Research Council, University of Sussex, and in the Department of Zoology, University of Toronto, he served on the faculty of the Department of Entomology at Oregon State University (1981-1991). He moved to the University of Arizona as professor of entomology (1991-2000) and then joined INRA at the Sophia Antipolis Research Center.

Feyereisen's early studies described the roles of P450 enzymes in the biosynthesis of ecdysteroids and juvenile hormones (JH). His laboratory has also made major contributions to the biochemistry of the corpora allata and to the discovery of allatostatins as "brain-gut" neuropeptides that are powerful inhibitors of JH synthesis. More recently, in collaboration with Gary Blomquist's group, Feyereisen showed that highly conserv
'/>"/>

Contact: Richard Levine
rlevine@entsoc.org
301-731-4535
Entomological Society of America
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology news :

1. Entomological Society of America launches science policy program
2. Entomological Society of America names 2012 Honorary Members
3. American Chemical Society podcast: Cotton is an eco-friendly way to clean up oil spills
4. New American Chemical Society video on a real stinker: The corpse flowers odor
5. American Chemical Society launches 2013 edition of popular Prized Science video series
6. 2013 medals and awards of the Geological Society of America
7. MARC travel awards announced for the 27th Protein Society Symposium 2013
8. MARC travel awards announced for the 2013 Society for the Study of Reproduction Meeting
9. The American Society for Microbiology honors Frank Leo van de Veerdonk
10. The American Society for Microbiology honors Baligh Yehia
11. The American Society for Microbiology honors George L. Drusano
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... 2015 According to a new ... Software, Services, Vertical (BFSI, Airport, IT & Telecom, Utilities, ... Forecast to 2020", published by MarketsandMarkets, defines and segments ... various segments. The global PIAM Market is estimated to ... by 2019, at a CAGR of 14.9 % from ...
(Date:8/3/2015)... Calif. , Aug. 3, 2015 Synaptics, ... human interface solutions, today announced that members of the ... at the Pacific Crest Global Technology Leadership Forum on ... The conference will be held at the Sonnenalp Resort ... The presentation may include forward-looking information. An audio ...
(Date:7/31/2015)... , 31 de julio de 2015 La 10 ... se celebrará por medio de BGI del 22 al 25 de ... Este año, la conferencia celebra su décimo ... ha convertido en una de las reuniones anuales más influyentes ... de las reuniones más dinámicas, entusiastas y mejores a nivel ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... Ore. After being hunted to local extinction more than ... grounds, the southern right whales of mainland New Zealand are ... for the first time that whales from a small surviving ... to the New Zealand mainland. Before the onslaught of ...
... Queen Mary, University of London, sheds new light on why ... can suffer organ damage in parts of the body which ... today in Nature Immunology *, examines the way certain ... to defend damaged organs against injury or infection. This ...
... therapy technique called genome editing that hones in on ... the blood clotting disorder hemophilia in mice. This is ... and repairs a genetic defect, has been done in ... As such, it represents an important step forward in ...
Cached Biology News:Fighting back from extinction, New Zealand right whale is returning home 2Fighting back from extinction, New Zealand right whale is returning home 3Rogue blood cells may contribute to post-surgery organ damage 2Genome editing, a next step in genetic therapy, corrects hemophilia in animals 2Genome editing, a next step in genetic therapy, corrects hemophilia in animals 3
(Date:9/1/2015)...   Medfusion, Inc., a patient engagement ... and patients, today announced a $3 million investment ... venture capital firms.   "We welcome ... City Venture Partners and Hatteras Venture Partners," said ... Chairman. "Both firms, experience working at the intersection ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... announced the release of a groundbreaking new version of its flagship DNA design ... methodology breaks down complex DNA sequences into numerous genetic parts, which in turn ...
(Date:8/31/2015)... ... 31, 2015 , ... In recent years, biodegradable plastics have ... carbon footprints and compostability. These properties can help in limiting the degradation of ... of applications, the market for biodegradable plastics can be broadly segmented into packaging, ...
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/53wxp3/israel_biomedical ) has ... Market - Growth, Trends & Forecasts (2014-2020)" report ... Sensors market is estimated at $0.19 billion by 2018 ... The near future will bring biomedical sensors ... individual. These sensors can be set to trigger alerts ...
Breaking Biology Technology:Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 2Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 3GenoCAD Releases Combinatorial Design Tool to Optimize Protein Expression and Streamline DNA Synthesis Orders 2Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 2Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 3Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 4Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 5Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2
... Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced ... approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme ... patients refractory to conventional therapy.  Chronic gout that is ... failed to normalize serum uric acid and whose signs ...
... DSM Biomedical , a global leader in biomedical ... today announced the company has extended its partnership with ... a dynamic stabilization system for the spine. Spinelab,s Elaspine™ ... for the degenerative lumbar spine, uses Bionate ® ...
... Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) announced ... and European fidaxomicin Phase 3 clinical trials in patients ... 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy ... Cornely, M.D., of the University of Cologne, presented data ...
Cached Biology Technology:FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 2FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 3FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 4FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 5FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 6FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 7FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy 8DSM Biomedical Announces Continued Partnership with Spinelab 2DSM Biomedical Announces Continued Partnership with Spinelab 3Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC 2Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC 3Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC 4Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC 5